Partnership

Our teams live and work in each market. Country managers build payer relationships over years — not quarterly visits from regional headquarters.

One alliance manager, one contract, one reporting structure. You focus on your pipeline — we handle regulatory, market access, and commercial execution across all countries simultaneously.

Our market access team has direct experience with local authorities and national HTA bodies, know reimbursement and negotiation process.

Specialty and rare disease products make up the largest and fastest-growing part of our portfolio. We understand patient identification, KOL engagement, and named-patient pathways.

We share regular market sizing analyses, competitor tracking, and reimbursement landscape updates. You get a strategic partner, not a logistics vendor.

Large enough to operate across region, agile enough to adapt to a single-product launch strategy. You won't be deprioritized by a global P&L dominated by big pharma clients.